Intervention

fosamprenavir/ritonavir

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions5

Lead sponsors shown4

Clinical trials

4 shown

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)NCT00977301 · 2009-11-01

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected SubjectsNCT01010399 · 2009-09-01

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsNCT00450580 · 2007-03-01

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After PregnancyNCT00042289 · 2003-06-09

Common conditions

HIV Infections2 HIV Infection1 HIV-1 Infection1 Hypertriglyceridemia1 Infection, Human Immunodeficiency Virus I1

Leading sponsors

Felizarta, Franco, M.D.1 National Institute of Allergy and Infectious Diseases (NIAID)1 Radboud University Medical Center1 ViiV Healthcare1

Trial status mix

COMPLETED4

Phase mix

PHASE11

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.